• 1. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 2. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 3. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 4. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 5. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147

• Catalysts and Inorganic Chemicals Inorganic Compounds Homogeneous non-metal compounds Homogeneous other non-metal compounds

5-Pyrimidinecarbonitrile, 2-chloro-4-(methylamino)

The compound 5-Pyrimidinecarbonitrile, 2-chloro-4-(methylamino), also identified by the CAS number 389606-74-0, is a significant molecule in the field of organic chemistry and drug discovery. This compound belongs to the class of pyrimidine derivatives, which are widely studied due to their potential biological activities and applications in pharmaceuticals. The structure of this compound features a pyrimidine ring with substituents at positions 2, 4, and 5. Specifically, the 2-position bears a chlorine atom, the 4-position is substituted with a methylamino group (-NCH3), and the 5-position contains a cyano group (-CN). These substituents contribute to the unique chemical properties and reactivity of the molecule.

Recent studies have highlighted the importance of pyrimidine derivatives in medicinal chemistry. For instance, researchers have explored the role of 5-Pyrimidinecarbonitrile, 2-chloro-4-(methylamino) in various biological systems. One notable area of investigation is its potential as a kinase inhibitor. Kinases are enzymes that play critical roles in cell signaling pathways, and their dysregulation is implicated in numerous diseases, including cancer. By inhibiting specific kinases, compounds like 5-Pyrimidinecarbonitrile could offer therapeutic benefits in treating these conditions.

In addition to its kinase inhibitory properties, this compound has been studied for its ability to modulate other enzymatic activities. For example, recent research has demonstrated its potential as an inhibitor of histone deacetylases (HDACs), which are enzymes involved in chromatin remodeling and gene expression regulation. HDAC inhibitors are of interest in cancer therapy due to their ability to reactivate tumor suppressor genes that have been silenced by epigenetic modifications.

The synthesis of 5-Pyrimidinecarbonitrile, 2-chloro-4-(methylamino) involves a multi-step process that typically begins with the preparation of a pyrimidine ring system. This is followed by substitution reactions to introduce the desired functional groups at specific positions on the ring. The use of advanced synthetic techniques, such as microwave-assisted synthesis or catalytic methods, has enabled researchers to optimize the production process and improve yields.

Beyond its direct applications in drug discovery, this compound serves as a valuable building block for constructing more complex molecular architectures. Its reactivity at the cyano group and amino group positions makes it amenable to further functionalization. For example, the cyano group can undergo nucleophilic substitution or addition reactions, while the amino group can participate in various condensation reactions or be converted into other nitrogen-containing functionalities.

In terms of pharmacokinetics and toxicity profiles, preliminary studies suggest that 5-Pyrimidinecarbonitrile exhibits moderate solubility in aqueous solutions and demonstrates acceptable absorption properties in preclinical models. However, further investigations are required to fully understand its pharmacokinetic behavior and potential toxicity in vivo.

The development of analogs based on this compound has also been an active area of research. By modifying the substituents on the pyrimidine ring, scientists aim to enhance specific properties such as bioavailability, selectivity for target enzymes, or stability within biological systems. For instance, replacing the chlorine atom with other halogens or altering the amino group could lead to compounds with improved therapeutic profiles.

In conclusion, 5-Pyrimidinecarbonitrile, with its unique structural features and promising biological activities, represents a valuable molecule in contemporary medicinal chemistry research. Its potential as a kinase inhibitor and HDAC modulator positions it as a candidate for further exploration in drug development pipelines. Continued research into its synthesis methods, pharmacokinetics, and toxicity will be essential for unlocking its full therapeutic potential. ]]>

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)